Faster transseptal puncture and reduced fluoroscopy
The VersaCross™ radiofrequency (RF) wire-based transseptal workflow for RF ablation resulted in a faster time to transseptal puncture, compared to an RF needle-based workflow.
Key takeaways
Achieved 25% faster time to first transseptal puncture (TSP)
Achieved 32% faster total TSP time
Observed 30% lower trend for overall fluoroscopy time
25% faster time to first TSP, with less variability in procedure time
![Bar chart illustrating time to first transseptal puncture from use of the RF wire-based VersaCross RF Transseptal Solution or an RF needle.](/en-EU/products/transseptal-access/faster-transseptal-puncture-reduced-fluoroscopy/_jcr_content/root/container/container/container/container_10285768/container_1448005214/image.coreimg.jpeg/1704183314007/infographic-versacross-faster-first-tsp-dewland-2023-figure-a-960x720.jpeg)
32% faster total TSP time, with less variability in procedure time*
![Bar chart illustrating combined transseptal puncture time from use of the RF wire-based VersaCross RF Transseptal Solution or an RF needle.](/en-EU/products/transseptal-access/faster-transseptal-puncture-reduced-fluoroscopy/_jcr_content/root/container/container/container/container_10285768_c/container_1448005214/image.coreimg.jpeg/1704183341987/infographic-versacross-faster-combined-tsp-dewland-2023-figure-b-960x720.jpeg)
30% lower trend for overall fluoroscopy time*
![Bar chart illustrating fluoroscopy time from use of the RF wire-based VersaCross RF Transseptal Solution or an RF needle.](/en-EU/products/transseptal-access/faster-transseptal-puncture-reduced-fluoroscopy/_jcr_content/root/container/container/container/container_10285768_c_1833546238/container_1448005214/image.coreimg.jpeg/1709328870366/infographic-versacross-reduced-fluoroscopy-dewland-2023-figure-c-960x720.jpeg)
Transseptal reimagined.
More about this study
Products in this study
![VersaCross Access Solution.](/en-EU/products/transseptal-access/faster-transseptal-puncture-reduced-fluoroscopy/_jcr_content/root/container/container/container/container_2130279479/image_1648108885_cop.coreimg.jpeg/1702341731471/versacross-access-solution-1.jpeg)
VersaCrossTM Access Solution
![VersaCross Access Solution.](/en-EU/products/transseptal-access/faster-transseptal-puncture-reduced-fluoroscopy/_jcr_content/root/container/container/container/container_2130279479_1237122445/image_1648108885_cop.coreimg.jpeg/1704183855865/photo-equipment-versacross-steerable-detail-3000x3000.jpeg)
VersaCrossTM Steerable Access Solution
References:
- Dewland, T.A., et al. (2022). Randomized Comparison of a Radiofrequency Wire Versus a Radiofrequency Needle System for Transseptal Puncture. JACC Clin Electrophysiol, 9(5), 611-619. doi: 10.1016/j.jacep.2022.10.017
* A double transseptal puncture was used in 30 (83%) participants in the RF needle group and 35 (90%) in the RF wire group (P = 0.41), and the remaining participants underwent single transseptal puncture.
Normally distributed continuous variables are presented as mean and non-normally distributed continuous variables represented as median (IQR).
All trademarks are the property of their respective owners.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.